ADAPT Program for Post Intensive Care Syndrome
(ADAPT Trial)
Trial Summary
The trial information does not specify whether you need to stop taking your current medications.
Research suggests that follow-up consultations and critical care transition programs can help ICU survivors by reducing readmissions and improving survival rates, which may indicate that structured post-ICU care like ADAPT could be beneficial.
12345The research articles do not provide specific safety data for the ADAPT Program or similar interventions for Post Intensive Care Syndrome, but they highlight the importance of careful management and follow-up care for ICU survivors to prevent complications.
16789The ADAPT treatment is unique because it focuses on anticipating decline and providing therapy early, which may include very early physical rehabilitation and case management interventions, unlike standard care that often involves later interventions. This proactive approach aims to improve long-term outcomes for ICU survivors by addressing physical, cognitive, and psychological health issues associated with post-intensive care syndrome.
1231011Eligibility Criteria
This trial is for older adults aged 60 or above who have been discharged from the ICU and may be at risk of post-intensive care syndrome, dementia, or other cognitive impairments. Specific eligibility details are not provided.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Cognitive Screening
Participants receive a routine validated cognitive screen at 6 weeks post-ICU discharge
Specialized Care Plan Development
Eligible participants complete a specialized care plan development visit
Follow-up
Participants are monitored for safety and effectiveness after treatment